The quality of care in type 1 and type 2 diabetes - A 2023 update of the AMD Annals Initiative.

An initiative of continuous monitoring of the quality of diabetes care, promoted by the Association of Medical Diabetologists, is in place in Italy since 2006 (AMD Annals). The initiative was effective in improving quality of care indicators, assessed periodically through standardized measures. Here, we show the 2023 AMD Annals data on type 2 (T2D) and type 1 (T1D) diabetes. A network of over 1/3 of diabetes centers in Italy periodically extracts anonymous data from electronic medical records, using a standardized software. Process, treatment and outcome indicators, and a validated score of overall care, the Q-score, were evaluated. 296 centers provided data on 573,164 T2D (mean age 69.7±11.2 years) and 42,611 T1D subjects (mean age 48.6±16.9 years). A HbA1c value ≤7.0% was documented in 56.3% of patients with T2D and 35.9% of those with T1D. Only 6.6% of T2D patients and 3.5% of those with T1D reached the composite outcome of HbA1c ≤7.0% + LDL-C <70 mg/dl + BP <130/80 mmHg. Notably, only 2.8% and 3.2% of T2D and T1D patients, respectively, showed a Q score <15, which correlates with an 80% higher risk of incident CVD events compared to scores >25. We documented an overall good quality of care in both T1D and T2D subjects. However, the failure to achieve the targets of the main risk factors, especially if combined, in a still too large proportion of patients testify the difficulty to apply the more and more stringent indications recommended by guidelines in the everyday clinical practice.

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.